Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications.

Abstract

One implication of this finding is that patients in the first 5 years of exposure could be targeted for prevention programs if resources are limited. A potential methodological problem encountered when studying chronically exposed patients is that they may have acquired TD (persistent) prior to the study and remitted before entry.